BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer

Judith E Carser, Jennifer E Quinn, Caroline O Michie, Eamonn J O'Brien, W Glenn McCluggage, Perry Maxwell, Elisabeth Lamers, Tong F Lioe, Alistair R W Williams, Richard D Kennedy, Charles Gourley, D Paul Harkin

Research output: Contribution to journalArticlepeer-review

Abstract

We investigated the relationship between BRCA1 protein expression by immunohistochemistry (IHC) and clinical outcome following platinum and platinum/taxane chemotherapy in sporadic epithelial ovarian cancer (EOC).
Original languageEnglish
Pages (from-to)492-8
Number of pages7
JournalGynecologic Oncology
Volume123
Issue number3
DOIs
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this